← Leaderboards
Charles B Hicks
Duke University
$1,288,270
Attributed
$1,288,270
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,288,270 · 2
By mechanism
M01$1,288,270 · 2
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Mary Louise Markert$14,079,588
- John A Bartlett$46,300,629
- Xiao-Fan Wang$23,927,835
- John S March$15,639,395
- Dan Gabriel Duda$6,457,636
Others in their field
Top investigators on “Aids Therapy”
- Lawrence Corey · Fred Hutchinson Cancer Center$356,191,804
- Constance Ann Benson · University Of California, San Diego$277,003,036
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$262,875,323
- Barbara Driver · Westat, Inc.$205,980,213
- Sharon A Nachman · Johns Hopkins University$193,704,208
- Carol Nesel · Westat$188,148,170
Research focus
Aids TherapyClinical ResearchHiv InfectionsHuman SubjectHuman Therapy EvaluationProtease InhibitorCombination TherapyDrug Screening /EvaluationFlow CytometryRitonavirThymus TransplantationT LymphocyteLamivudineOral AdministrationPharmacokineticsAntiaids AgentBiopsyCd4 MoleculeZidovudineClinical Trials
Grant awards (12)
COMBINATION ANTIRETROVIRAL THERAPY &THYMUS TRANSPLANTATION IN HIV INFECTION$117,022
M01 · FY2002 · RR
ABT378/RITONAVIR WITH RT INHIBITORS IN ANTIRETROVIRAL NAIVE HIV INFECTED PATIENTS$117,022
M01 · FY2002 · RR
COMBINATION ANTIRETROVIRAL THERAPY &THYMUS TRANSPLANTATION IN HIV INFECTION$293,069
M01 · FY2001 · RR
ABT378/RITONAVIR WITH RT INHIBITORS IN ANTIRETROVIRAL NAIVE HIV INFECTED PATIENTS$293,069
M01 · FY2001 · RR
COMBINATION ANTIRETROVIRAL THERAPY &THYMUS TRANSPLANTATION IN HIV INFECTION$117,022
M01 · FY2001 · RR
COMBINATION ANTIRETROVIRAL THERAPY &THYMUS TRANSPLANTATION IN HIV INFECTION$117,022
M01 · FY2001 · RR
ABT378/RITONAVIR WITH RT INHIBITORS IN ANTIRETROVIRAL NAIVE HIV INFECTED PATIENTS$117,022
M01 · FY2001 · RR
ABT378/RITONAVIR WITH RT INHIBITORS IN ANTIRETROVIRAL NAIVE HIV INFECTED PATIENTS$117,022
M01 · FY2001 · RR
ABT378/RITONAVIR WITH RT INHIBITORS IN ANTIRETROVIRAL NAIVE HIV INFECTED PATIENTS$0
M01 · FY2000 · RR
ABT378/RITONAVIR WITH RT INHIBITORS IN ANTIRETROVIRAL NAIVE HIV INFECTED PATIENTS$0
M01 · FY2000 · RR
COMBINATION ANTIRETROVIRAL THERAPY &THYMUS TRANSPLANTATION IN HIV INFECTION$0
M01 · FY2000 · RR
COMBINATION ANTIRETROVIRAL THERAPY &THYMUS TRANSPLANTATION IN HIV INFECTION$0
M01 · FY2000 · RR